NICE's methodology means people with cancer aren't getting drugs - AstraZeneca's Sir Pascal Soriot said

The chief executive of AstraZeneca has criticised a public health body for refusing to make one of its breast cancer treatments available to NHS patients in England and Wales.

The full article is no longer available.